Cargando…

Nephroprotective effects of Candesartan Cilexetil against Cyclosporine A-induced nephrotoxicity in a rat model

Cyclosporine A (CsA), a well-known immunosuppressive drug, has been prescribed after organ transplantation and in a variety of disorders with an immunological origin. Nephrotoxicity is one of the most frequently stated problems associated with CsA, and therefore the treatment with CsA remains a big...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghafil, Fadhaa Abdulameer, Kadhim, Samah Abdulridha Abdul, Majeed, Sahar, Qassam, Heider, Hadi, Najah Rayish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Carol Davila University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884341/
https://www.ncbi.nlm.nih.gov/pubmed/36762326
http://dx.doi.org/10.25122/jml-2021-0227
_version_ 1784879696308076544
author Ghafil, Fadhaa Abdulameer
Kadhim, Samah Abdulridha Abdul
Majeed, Sahar
Qassam, Heider
Hadi, Najah Rayish
author_facet Ghafil, Fadhaa Abdulameer
Kadhim, Samah Abdulridha Abdul
Majeed, Sahar
Qassam, Heider
Hadi, Najah Rayish
author_sort Ghafil, Fadhaa Abdulameer
collection PubMed
description Cyclosporine A (CsA), a well-known immunosuppressive drug, has been prescribed after organ transplantation and in a variety of disorders with an immunological origin. Nephrotoxicity is one of the most frequently stated problems associated with CsA, and therefore the treatment with CsA remains a big challenge. This study sets out to assess the ameliorative influences of Candesartan Cilexetil (CC) on oxidative stress and the nephrotoxic effect of CsA in a rat model. Twenty-four Wister Albino rats, 7–8-week-old, weighing 150–250g, were randomly categorized into three groups (eight animals in each group). These groups were the (1) CsA-treated group, (2) vehicle-treated group, and (3) CC-treated group. Bodyweights were assessed at the start and end of experiments. Renal function test and levels of glutathione peroxidase 1 catalase -CAT (Gpx1), catalase (CAT), superoxide dismutase (SOD), interleukin -2 (IL-2), and malondialdehyde (MDA) were investigated in renal tissues. Histological changes in kidneys were also evaluated. Data showed that levels of urea and creatinine in serum and levels of IL-2 and MDA in renal tissues were elevated in the CsA-treated group, with severe histological changes compared with the control group. Furthermore, tissue levels of Gpx1, CAT, and SOD were significantly decreased in CsA-treated in comparison with the control group. Treatment with CC for the rats subjected to CSA resulted in a marked reduction in levels of serum urea and creatinine and tissue levels of IL-2 and MDA. Levels of Gpx1, CAT, and SOD in renal tissues were greater in the CC-treatment group compared with the CsA-treated group. CC treatment reduced the deterioration of renal morphology compared with CsA treatment. The findings of this study suggest that CC could prevent CSA-induced nephrotoxicity through its anti-inflammatory and antioxidant influences. Considerably more work needs to be done to determine the mechanistic insight behind the ameliorative effect of CC.
format Online
Article
Text
id pubmed-9884341
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Carol Davila University Press
record_format MEDLINE/PubMed
spelling pubmed-98843412023-02-08 Nephroprotective effects of Candesartan Cilexetil against Cyclosporine A-induced nephrotoxicity in a rat model Ghafil, Fadhaa Abdulameer Kadhim, Samah Abdulridha Abdul Majeed, Sahar Qassam, Heider Hadi, Najah Rayish J Med Life Original Article Cyclosporine A (CsA), a well-known immunosuppressive drug, has been prescribed after organ transplantation and in a variety of disorders with an immunological origin. Nephrotoxicity is one of the most frequently stated problems associated with CsA, and therefore the treatment with CsA remains a big challenge. This study sets out to assess the ameliorative influences of Candesartan Cilexetil (CC) on oxidative stress and the nephrotoxic effect of CsA in a rat model. Twenty-four Wister Albino rats, 7–8-week-old, weighing 150–250g, were randomly categorized into three groups (eight animals in each group). These groups were the (1) CsA-treated group, (2) vehicle-treated group, and (3) CC-treated group. Bodyweights were assessed at the start and end of experiments. Renal function test and levels of glutathione peroxidase 1 catalase -CAT (Gpx1), catalase (CAT), superoxide dismutase (SOD), interleukin -2 (IL-2), and malondialdehyde (MDA) were investigated in renal tissues. Histological changes in kidneys were also evaluated. Data showed that levels of urea and creatinine in serum and levels of IL-2 and MDA in renal tissues were elevated in the CsA-treated group, with severe histological changes compared with the control group. Furthermore, tissue levels of Gpx1, CAT, and SOD were significantly decreased in CsA-treated in comparison with the control group. Treatment with CC for the rats subjected to CSA resulted in a marked reduction in levels of serum urea and creatinine and tissue levels of IL-2 and MDA. Levels of Gpx1, CAT, and SOD in renal tissues were greater in the CC-treatment group compared with the CsA-treated group. CC treatment reduced the deterioration of renal morphology compared with CsA treatment. The findings of this study suggest that CC could prevent CSA-induced nephrotoxicity through its anti-inflammatory and antioxidant influences. Considerably more work needs to be done to determine the mechanistic insight behind the ameliorative effect of CC. Carol Davila University Press 2022-12 /pmc/articles/PMC9884341/ /pubmed/36762326 http://dx.doi.org/10.25122/jml-2021-0227 Text en ©2022 JOURNAL of MEDICINE and LIFE https://creativecommons.org/licenses/by/3.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Original Article
Ghafil, Fadhaa Abdulameer
Kadhim, Samah Abdulridha Abdul
Majeed, Sahar
Qassam, Heider
Hadi, Najah Rayish
Nephroprotective effects of Candesartan Cilexetil against Cyclosporine A-induced nephrotoxicity in a rat model
title Nephroprotective effects of Candesartan Cilexetil against Cyclosporine A-induced nephrotoxicity in a rat model
title_full Nephroprotective effects of Candesartan Cilexetil against Cyclosporine A-induced nephrotoxicity in a rat model
title_fullStr Nephroprotective effects of Candesartan Cilexetil against Cyclosporine A-induced nephrotoxicity in a rat model
title_full_unstemmed Nephroprotective effects of Candesartan Cilexetil against Cyclosporine A-induced nephrotoxicity in a rat model
title_short Nephroprotective effects of Candesartan Cilexetil against Cyclosporine A-induced nephrotoxicity in a rat model
title_sort nephroprotective effects of candesartan cilexetil against cyclosporine a-induced nephrotoxicity in a rat model
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884341/
https://www.ncbi.nlm.nih.gov/pubmed/36762326
http://dx.doi.org/10.25122/jml-2021-0227
work_keys_str_mv AT ghafilfadhaaabdulameer nephroprotectiveeffectsofcandesartancilexetilagainstcyclosporineainducednephrotoxicityinaratmodel
AT kadhimsamahabdulridhaabdul nephroprotectiveeffectsofcandesartancilexetilagainstcyclosporineainducednephrotoxicityinaratmodel
AT majeedsahar nephroprotectiveeffectsofcandesartancilexetilagainstcyclosporineainducednephrotoxicityinaratmodel
AT qassamheider nephroprotectiveeffectsofcandesartancilexetilagainstcyclosporineainducednephrotoxicityinaratmodel
AT hadinajahrayish nephroprotectiveeffectsofcandesartancilexetilagainstcyclosporineainducednephrotoxicityinaratmodel